Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction.

Nepper-Christensen L, Høfsten DE, Helqvist S, Lassen JF, Tilsted HH, Holmvang L, Pedersen F, Joshi F, Sørensen R, Bang L, Bøtker HE, Terkelsen CJ, Maeng M, Jensen LO, Aarøe J, Kelbæk H, Køber L, Engstrøm T, Lønborg J.

Heart. 2019 Jul 17. pii: heartjnl-2019-314952. doi: 10.1136/heartjnl-2019-314952. [Epub ahead of print]

PMID:
31315939
2.

Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI.

Laursen PN, Holmvang L, Lønborg J, Køber L, Høfsten DE, Helqvist S, Clemmensen P, Kelbæk H, Jørgensen E, Lassen JF, Pedersen F, Høi-Hansen T, Raungaard B, Terkelsen CJ, Jensen LO, Sadjadieh G, Engstrøm T.

Int J Cardiol. 2019 Aug 15;289:1-5. doi: 10.1016/j.ijcard.2019.04.064. Epub 2019 May 1.

PMID:
31078351
3.

Impact of Multiple Myocardial Scars Detected by CMR in Patients Following STEMI.

Ekström K, Nepper-Christensen L, Ahtarovski KA, Kyhl K, Göransson C, Bertelsen L, Ghotbi AA, Kelbæk H, Helqvist S, Høfsten DE, Køber L, Schoos MM, Vejlstrup N, Lønborg J, Engstrøm T.

JACC Cardiovasc Imaging. 2019 Apr 10. pii: S1936-878X(19)30241-4. doi: 10.1016/j.jcmg.2019.01.032. [Epub ahead of print]

PMID:
31005537
4.

Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.

Kyhl K, Ahtarovski KA, Nepper-Christensen L, Ekström K, Ghotbi AA, Schoos M, Göransson C, Bertelsen L, Helqvist S, Holmvang L, Jørgensen E, Pedersen F, Saunamäki K, Clemmensen P, De Backer O, Høfsten DE, Køber L, Kelbæk H, Vejlstrup N, Lønborg J, Engstrøm T.

JACC Cardiovasc Interv. 2019 Apr 22;12(8):721-730. doi: 10.1016/j.jcin.2019.01.248.

PMID:
31000010
5.

Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy.

De Backer O, Lønborg J, Helqvist S, Warnøe J, Kløvgaard L, Holmvang L, Pedersen F, Tilsted HH, Raungaard B, Jørgensen E, Køber L, Høfsten DE, Kelbæk H, Engstrøm T.

EuroIntervention. 2019 Jun 20;15(2):172-179. doi: 10.4244/EIJ-D-18-00766.

6.

Deferred vs Immediate Stenting in Primary Percutaneous Coronary Intervention: A Collaborative Meta-analysis of Randomized Trials With Cardiac Magnetic Resonance Imaging Data.

Cassese S, Belle L, Ndrepepa G, Bosson JL, Fusaro M, Lønborg J, Ahtarovski KA, Kelbæk H, Fusaro M.

Can J Cardiol. 2018 Dec;34(12):1573-1580. doi: 10.1016/j.cjca.2018.07.480. Epub 2018 Aug 7.

PMID:
30527145
7.

Borderline multivessel coronary artery disease assessed by fractional flow reserve-affecting practice?

Lønborg J, Engstrøm T.

J Thorac Dis. 2018 Sep;10(Suppl 26):S3078-S3080. doi: 10.21037/jtd.2018.07.129. No abstract available.

8.

Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction.

Nepper-Christensen L, Lønborg J, Høfsten DE, Ahtarovski KA, Bang LE, Helqvist S, Kyhl K, Køber L, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T.

Circ Cardiovasc Interv. 2018 Sep;11(9):e006842. doi: 10.1161/CIRCINTERVENTIONS.118.006842.

PMID:
30354595
9.

Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.

Kobayashi Y, Lønborg J, Jong A, Nishi T, De Bruyne B, Høfsten DE, Kelbæk H, Layland J, Nam CW, Pijls NHJ, Tonino PAL, Warnøe J, Oldroyd KG, Berry C, Engstrøm T, Fearon WF; DANAMI-3-PRIMULTI, FAME, and FAMOUS-NSTEMI Study Investigators.

J Am Coll Cardiol. 2018 Sep 18;72(12):1321-1329. doi: 10.1016/j.jacc.2018.06.069.

PMID:
30213322
10.

Importance of elevated heart rate in the very early phase of ST-segment elevation myocardial infarction: Results from the DANAMI-3 trial.

Nepper-Christensen L, Lønborg J, Ahtarovski KA, Høfsten DE, Kyhl K, Schoos MM, Göransson C, Laursen PN, Sadjadieh G, Ghotbi AA, Bertelsen L, Køber L, Helqvist S, Pedersen F, Jørgensen E, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T.

Eur Heart J Acute Cardiovasc Care. 2019 Jun;8(4):318-328. doi: 10.1177/2048872618795515. Epub 2018 Aug 23.

PMID:
30136597
11.

Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study.

Laursen PN, Holmvang L, Lønborg J, Køber L, Høfsten DE, Helqvist S, Clemmensen P, Kelbæk H, Jørgensen E, Lassen JF, Pedersen F, Høi-Hansen T, Therkelsen CJ, Tilsted HH, Jensen LO, Nepper-Christensen L, Sadjadieh G, Engstrøm T.

Am Heart J. 2018 Oct;204:128-138. doi: 10.1016/j.ahj.2018.05.018. Epub 2018 Aug 10.

PMID:
30103092
12.

Assessment of the myocardial area at risk: comparing T2-weighted cardiovascular magnetic resonance imaging with contrast-enhanced cine (CE-SSFP) imaging-a DANAMI3 substudy.

Göransson C, Ahtarovski KA, Kyhl K, Lønborg J, Nepper-Christensen L, Bertelsen L, Ghotbi AA, Schoos MM, Køber L, Høfsten D, Helqvist S, Kelbæk H, Engstrøm T, Vejlstrup N.

Eur Heart J Cardiovasc Imaging. 2019 Mar 1;20(3):361-366. doi: 10.1093/ehjci/jey106.

PMID:
30085055
13.

Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: too early to draw conclusions.

Lønborg J, Engstrøm T, De Backer O, Søndergaard L.

EuroIntervention. 2018 Aug 3;14(5):e487-e489. doi: 10.4244/EIJV14I5A85. No abstract available.

14.

Can copeptin and troponin T ratio predict final infarct size and myocardial salvage index in patients with ST-elevation myocardial infarction: A sub-study of the DANAMI-3 trial.

Árnadóttir Á, Schoos M, Lønborg J, Ahtarovski K, Kelbæk H, Helqvist S, Høfsten D, Clemmensen P, Engstrøm T, Nepper-Christensen L, Vejlstrup N, Køber L, Iversen K.

Clin Biochem. 2018 Sep;59:37-42. doi: 10.1016/j.clinbiochem.2018.06.012. Epub 2018 Jun 20.

PMID:
29932892
15.

Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.

Engstrøm T, Nepper-Christensen L, Helqvist S, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamaki K, Tilsted HH, Steensberg A, Fabricius S, Mouritzen U, Vejlstrup N, Ahtarovski KA, Göransson C, Bertelsen L, Kyhl K, Olivecrona G, Kelbæk H, Lassen JF, Køber L, Lønborg J.

Heart. 2018 Oct;104(19):1593-1599. doi: 10.1136/heartjnl-2017-312774. Epub 2018 Mar 30.

PMID:
29602883
16.

Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy.

Nepper-Christensen L, Lønborg J, Høfsten DE, Ahtarovski KA, Kyhl K, Göransson C, Køber L, Helqvist S, Pedersen F, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T.

EuroIntervention. 2018 Aug 20;14(6):700-707. doi: 10.4244/EIJ-D-17-00857.

17.

Is ischemic postconditioning in STEMI worth pursuing?

Engstrøm T, Lønborg J.

J Thorac Dis. 2017 Nov;9(11):E1035-E1036. doi: 10.21037/jtd.2017.10.65. No abstract available.

18.

Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry.

Millan-Iturbe O, Sawaya FJ, Lønborg J, Chow DHF, Bieliauskas G, Engstrøm T, Søndergaard L, De Backer O.

Catheter Cardiovasc Interv. 2018 Oct 1;92(4):818-826. doi: 10.1002/ccd.27440. Epub 2017 Dec 7.

PMID:
29214718
19.

Cardiovascular Magnetic Resonance for Risk Stratification in Patients With ST-Segment-Elevation Myocardial Infarction: A Novel Tool to Tailor Therapy or Emperor's New Clothes?

Lønborg J, Engstrøm T.

Circ Cardiovasc Imaging. 2017 Nov;10(11). pii: e007108. doi: 10.1161/CIRCIMAGING.117.007108. No abstract available.

PMID:
29146588
20.

Reply: Deferred Stenting in STEMI: Still an Interest in Selected Patients?

Lønborg J, Engstrøm T, Kelbæk H.

J Am Coll Cardiol. 2017 Oct 31;70(18):2312. doi: 10.1016/j.jacc.2017.08.060. No abstract available.

21.

Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention.

Campo G, Pavasini R, Morciano G, Lincoff MA, C Gibson M, Kitakaze M, Lonborg J, Ahluwalia A, Ishii H, Frenneaux M, Ovize M, Galvani M, Atar D, Ibanez B, Cerisano G, Biscaglia S, Neil BJ, Asakura M, Engstrom T, Jones DA, Dawson D, Ferrari R, Pinton P, Ottani F.

Data Brief. 2017 Jul 18;14:197-205. doi: 10.1016/j.dib.2017.07.033. eCollection 2017 Oct.

22.

Early risk stratification using Rubidium-82 positron emission tomography in STEMI patients.

Ghotbi AA, Hasbak P, Nepper-Christensen L, Lønborg J, Atharovski K, Christensen T, Holmvang L, Engstrøm T, Ripa RS, Kjær A.

J Nucl Cardiol. 2019 Apr;26(2):471-482. doi: 10.1007/s12350-017-0993-x. Epub 2017 Jul 17.

23.

Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials.

Campo G, Pavasini R, Morciano G, Lincoff AM, Gibson CM, Kitakaze M, Lonborg J, Ahluwalia A, Ishii H, Frenneaux M, Ovize M, Galvani M, Atar D, Ibanez B, Cerisano G, Biscaglia S, Neil BJ, Asakura M, Engstrom T, Jones DA, Dawson D, Ferrari R, Pinton P, Ottani F.

Int J Cardiol. 2017 Oct 1;244:59-66. doi: 10.1016/j.ijcard.2017.06.040. Epub 2017 Jun 13. Review.

PMID:
28634037
24.

Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3-DEFER Substudy.

Lønborg J, Engstrøm T, Ahtarovski KA, Nepper-Christensen L, Helqvist S, Vejlstrup N, Kyhl K, Schoos MM, Ghotbi A, Göransson C, Bertelsen L, Holmvang L, Pedersen F, Jørgensen E, Saunamäki K, Clemmensen P, De Backer O, Kløvgaard L, Høfsten DE, Køber L, Kelbæk H; DANAMI-3 Investigators.

J Am Coll Cardiol. 2017 Jun 13;69(23):2794-2804. doi: 10.1016/j.jacc.2017.03.601.

25.

Lack of effect of prolonged treatment with liraglutide on cardiac remodeling in rats after acute myocardial infarction.

Kyhl K, Lønborg J, Hartmann B, Kissow H, Poulsen SS, Ali HE, Kjær A, Dela F, Engstrøm T, Treiman M.

Peptides. 2017 Jul;93:1-12. doi: 10.1016/j.peptides.2017.04.009. Epub 2017 Apr 28.

PMID:
28460895
26.

Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).

Lønborg J, Engstrøm T, Kelbæk H, Helqvist S, Kløvgaard L, Holmvang L, Pedersen F, Jørgensen E, Saunamäki K, Clemmensen P, De Backer O, Ravkilde J, Tilsted HH, Villadsen AB, Aarøe J, Jensen SE, Raungaard B, Køber L, Høfsten DE; DANAMI 3-PRIMULTI Investigators.

Circ Cardiovasc Interv. 2017 Apr;10(4). pii: e004460. doi: 10.1161/CIRCINTERVENTIONS.116.004460.

PMID:
28404623
27.

Association Between Early Q Waves and Reperfusion Success in Patients With ST-Segment-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: A Cardiac Magnetic Resonance Imaging Study.

Topal DG, Lønborg J, Ahtarovski KA, Nepper-Christensen L, Helqvist S, Holmvang L, Pedersen F, Clemmensen P, Saünamaki K, Jørgensen E, Kyhl K, Ghotbi A, Schoos MM, Göransson C, Bertelsen L, Høfsten D, Køber L, Kelbæk H, Vejlstrup N, Engstrøm T.

Circ Cardiovasc Interv. 2017 Mar;10(3). pii: e004467. doi: 10.1161/CIRCINTERVENTIONS.116.004467.

PMID:
28264870
28.

Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial.

Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Clemmensen P, Holmvang L, Jørgensen E, Pedersen F, Saunamaki K, Ravkilde J, Tilsted HH, Villadsen A, Aarøe J, Jensen SE, Raungaard B, Bøtker HE, Terkelsen CJ, Maeng M, Kaltoft A, Krusell LR, Jensen LO, Veien KT, Kofoed KF, Torp-Pedersen C, Kyhl K, Nepper-Christensen L, Treiman M, Vejlstrup N, Ahtarovski K, Lønborg J, Køber L; Third Danish Study of Optimal Acute Treatment of Patients With ST Elevation Myocardial Infarction–Ischemic Postconditioning (DANAMI-3–iPOST) Investigators.

JAMA Cardiol. 2017 May 1;2(5):490-497. doi: 10.1001/jamacardio.2017.0022.

29.

Drop-out from cardiovascular magnetic resonance in a randomized controlled trial of ST-elevation myocardial infarction does not cause selection bias on endpoints.

Laursen PN, Holmvang L, Kelbæk H, Vejlstrup N, Engstrøm T, Lønborg J.

Clin Res Cardiol. 2017 Jul;106(7):525-532. doi: 10.1007/s00392-017-1081-6. Epub 2017 Feb 6.

PMID:
28168513
30.

Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Nepper-Christensen L, Lønborg J, Ahtarovski KA, Høfsten DE, Kyhl K, Ghotbi AA, Schoos MM, Göransson C, Bertelsen L, Køber L, Helqvist S, Pedersen F, Saünamaki K, Jørgensen E, Kelbæk H, Holmvang L, Vejlstrup N, Engstrøm T.

J Am Heart Assoc. 2017 Jan 9;6(1). pii: e004823. doi: 10.1161/JAHA.116.004823.

31.

Subacute cardiac rubidium-82 positron emission tomography (82Rb-PET) to assess myocardial area at risk, final infarct size, and myocardial salvage after STEMI.

Ghotbi AA, Kjaer A, Nepper-Christensen L, Ahtarovski KA, Lønborg JT, Vejlstrup N, Kyhl K, Christensen TE, Engstrøm T, Kelbæk H, Holmvang L, Bang LE, Ripa RS, Hasbak P.

J Nucl Cardiol. 2018 Jun;25(3):970-981. doi: 10.1007/s12350-016-0694-x. Epub 2016 Oct 14.

32.

A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction.

Kyhl K, Lønborg J, Vejlstrup N, Kelbæk H, Helqvist S, Holmvang L, Jørgensen E, Saunamäki K, Bøtker HE, Clemmensen P, Køber L, Treiman M, Engstrøm T.

EuroIntervention. 2016 Jul 20;12(4):449-55. doi: 10.4244/EIJV12I4A78.

33.

Comparison of Outcome of Patients With ST-Segment Elevation Myocardial Infarction and Complete Versus Incomplete ST-Resolution Before Primary Percutaneous Coronary Intervention.

Lønborg J, Kelbæk H, Holmvang L, Helqvist S, Vejlstrup N, Jørgensen E, Saunamäki K, Dridi NP, Kløvgaard L, Kaltoft A, Bøtker HE, Lassen JF, Clemmensen P, Terkelsen CJ, Engstrøm T.

Am J Cardiol. 2016 Jun 1;117(11):1735-40. doi: 10.1016/j.amjcard.2016.03.009. Epub 2016 Mar 18.

PMID:
27062938
34.

Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial.

Kelbæk H, Høfsten DE, Køber L, Helqvist S, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamäki K, De Backer O, Bang LE, Kofoed KF, Lønborg J, Ahtarovski K, Vejlstrup N, Bøtker HE, Terkelsen CJ, Christiansen EH, Ravkilde J, Tilsted HH, Villadsen AB, Aarøe J, Jensen SE, Raungaard B, Jensen LO, Clemmensen P, Grande P, Madsen JK, Torp-Pedersen C, Engstrøm T.

Lancet. 2016 May 28;387(10034):2199-206. doi: 10.1016/S0140-6736(16)30072-1. Epub 2016 Apr 3.

PMID:
27053444
35.

Association diastolic function by echo and infarct size by magnetic resonance imaging after STEMI.

Søholm H, Lønborg J, Andersen MJ, Vejlstrup N, Engstrøm T, Hassager C, Møller JE.

Scand Cardiovasc J. 2016 Jun;50(3):172-9. doi: 10.3109/14017431.2016.1163416. Epub 2016 May 10.

PMID:
26967196
36.

Long-term outcome of FFR-guided PCI for stable coronary artery disease in daily clinical practice: a propensity score-matched landmark analysis.

De Backer O, Biasco L, Lønborg J, Pedersen F, Holmvang L, Kelbaek H, Arnous S, Saunamäki K, Helqvist S, Kastrup J, Jørgensen E, Engstrøm T.

EuroIntervention. 2016 Feb;11(11):e1257-66. doi: 10.4244/EIJV11I11A247.

37.

Targeting reperfusion injury in the era of primary percutaneous coronary intervention: hope or hype?

Lønborg JT.

Heart. 2015 Oct;101(20):1612-8. doi: 10.1136/heartjnl-2015-307804. Epub 2015 Jun 30. Review.

PMID:
26130664
38.

Predictors and prognostic value of left atrial remodelling after acute myocardial infarction.

Kyhl K, Vejlstrup N, Lønborg J, Treiman M, Ahtarovski KA, Helqvist S, Kelbæk H, Holmvang L, Jørgensen E, Saunamäki K, Søholm H, Andersen MJ, Møller JE, Clemmensen P, Engstrøm T.

Open Heart. 2015 Jun 8;2(1):e000223. doi: 10.1136/openhrt-2014-000223. eCollection 2015.

39.

Angiographic characteristics of intermediate stenosis of the left anterior descending artery for determination of lesion significance as identified by fractional flow reserve.

Biasco L, Pedersen F, Lønborg J, Holmvang L, Helqvist S, Saunamäki K, Kelbaek H, Clemmensen P, Olivecrona GK, Jørgensen E, Engstrøm T, De Backer O.

Am J Cardiol. 2015 Jun 1;115(11):1475-80. doi: 10.1016/j.amjcard.2015.02.047. Epub 2015 Mar 11.

PMID:
25857401
40.

Recovery from anemia in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation--prevalence, predictors and clinical outcome.

De Backer O, Arnous S, Lønborg J, Brooks M, Biasco L, Jönsson A, Franzen OW, Søndergaard L.

PLoS One. 2014 Dec 1;9(12):e114038. doi: 10.1371/journal.pone.0114038. eCollection 2014.

41.

Repeated echocardiography after first ever ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention--is it necessary?

Søholm H, Lønborg J, Andersen MJ, Vejlstrup N, Engstrøm T, Møller JE, Hassager C.

Eur Heart J Acute Cardiovasc Care. 2015 Dec;4(6):528-36. doi: 10.1177/2048872614556000. Epub 2014 Oct 15.

PMID:
25318482
42.

Tailored antiplatelet therapy to improve prognosis in patients exhibiting clopidogrel low-response prior to percutaneous coronary intervention for stable angina or non-ST elevation acute coronary syndrome.

Paarup Dridi N, Johansson PI, Lønborg JT, Clemmensen P, Radu MD, Qayyum A, Pedersen F, Kollslid R, Helqvist S, Saunamäki K, Kelbæk H, Jørgensen E, Engstrøm T, Holmvang L.

Platelets. 2015;26(6):521-9. doi: 10.3109/09537104.2014.948837. Epub 2014 Aug 28.

PMID:
25166751
43.

ST peak during percutaneous coronary intervention serves as an early prognostic predictor in patients with ST-segment elevation myocardial.

Lønborg J, Kelbæk H, Engstrøm T, Helqvist S, Kløvgaard L, Holmvang L, Vejlstrup N, Jørgensen E, Saunamäki K, Dridi NP, Kaltoft A, Bøtker HE, Clemmensen P, Terkelsen CJ.

EuroIntervention. 2014 Aug;10(4):466-74. doi: 10.4244/EIJV10I4A80.

44.

The impact of distal embolization and distal protection on long-term outcome in patients with ST elevation myocardial infarction randomized to primary percutaneous coronary intervention--results from a randomized study.

Lønborg J, Kelbæk H, Helqvist S, Holmvang L, Jørgensen E, Saunamäki K, Kløvgaard L, Kaltoft A, Bøtker HE, Lassen JF, Thuesen L, Terkelsen CJ, Kofoed KF, Clemmensen P, Køber L, Engstrøm T.

Eur Heart J Acute Cardiovasc Care. 2015 Apr;4(2):180-8. doi: 10.1177/2048872614543780. Epub 2014 Jul 10.

PMID:
25013089
45.

Diminishing marginal disutility of hypoglycaemic events: results from a time trade-off survey in five countries.

Lauridsen JT, Lønborg J, Gundgaard J, Jensen HH.

Qual Life Res. 2014 Nov;23(9):2645-50. doi: 10.1007/s11136-014-0712-x. Epub 2014 May 17.

PMID:
24838908
46.

Impact of acute hyperglycemia on myocardial infarct size, area at risk, and salvage in patients with STEMI and the association with exenatide treatment: results from a randomized study.

Lønborg J, Vejlstrup N, Kelbæk H, Nepper-Christensen L, Jørgensen E, Helqvist S, Holmvang L, Saunamäki K, Bøtker HE, Kim WY, Clemmensen P, Treiman M, Engstrøm T.

Diabetes. 2014 Jul;63(7):2474-85. doi: 10.2337/db13-1849. Epub 2014 Feb 28.

47.

Takotsubo cardiomyopathy, a two-stage recovery of left ventricular systolic and diastolic function as determined by cardiac magnetic resonance imaging.

Ahtarovski KA, Iversen KK, Christensen TE, Andersson H, Grande P, Holmvang L, Bang L, Hasbak P, Lønborg JT, Madsen PL, Engstrøm T, Vejlstrup NG.

Eur Heart J Cardiovasc Imaging. 2014 Aug;15(8):855-62. doi: 10.1093/ehjci/jeu004. Epub 2014 Feb 12.

PMID:
24525137
48.

A mismatch index based on the difference between measured left ventricular ejection fraction and that estimated by infarct size at three months following reperfused acute myocardial infarction.

Carlsen EA, Bang LE, Lønborg J, Ahtarovski KA, Køber L, Kelbæk H, Vejlstrup N, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Wagner GS, Engstrøm T.

J Electrocardiol. 2014 Mar-Apr;47(2):191-6. doi: 10.1016/j.jelectrocard.2013.10.009. Epub 2013 Oct 31.

PMID:
24373864
49.

Correlating infarct size and patient prognosis: are cardiac biomarkers truly insufficient? Reply.

Lønborg J, Engstrøm T.

Eur Heart J Cardiovasc Imaging. 2013 Sep;14(9):932-3. No abstract available.

PMID:
24073450
50.

Reperfusion delay in patients treated with primary percutaneous coronary intervention: insight from a real world Danish ST-segment elevation myocardial infarction population in the era of telemedicine.

Schoos MM, Sejersten M, Hvelplund A, Madsen M, Lønborg J, Steinmetz J, Treschow PM, Pedersen F, Jørgensen E, Grande P, Kelbæk H, Clemmensen P.

Eur Heart J Acute Cardiovasc Care. 2012 Sep;1(3):200-9. doi: 10.1177/2048872612455143.

Supplemental Content

Loading ...
Support Center